A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab For Locally Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2015
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 30 Jun 2009 Additional lead trial investigator (Fanelle J, Haas A) identified as reported by New Jersey Cancer Trial Connect.
- 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect, RTOG0411).
- 05 Nov 2005 New trial record.